HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Data from various countries show considerable variation in the rate of spread of the human immunodeficiency virus (HIV) among drug injectors. Although further research is needed to predict the rate of increase of seroprevalence at Rio de Janeiro, preliminary data confirm the presence of the virus, with a seroprevalence of about 33 per cent in 1990. Issues arising from research into the probable determinants of viral spread among the thousands of drug injectors in the city are outlined in the present paper. Even before the research is completed, however, it is clear that interventions are needed to reduce further viral transmission both among drug injectors and from them to their sexual partners and offspring. Efforts should be made to prevent the population at risk from initiating the practice of drug injection, and to promote a major expansion in drug abuse treatment facilities. Drug injectors should also be encouraged to reduce the risk of their becoming infected or passing on the virus to others, through educational outreach, through the distribution of supplies that facilitate risk reduction (bleach, syringes, condoms), and through innovative approaches to behaviour change.
Lima
E S
ES
Nucleo de Estudos e Pesquisas em Atenção ao Uso de Drogas, University of Rio de Janeiro, Brazil.
Bastos
F I
FI
Telles
P R
PR
Friedman
S R
SR
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control / Q000635:transmission; D001938:Brazil / Q000453:epidemiology; D017280:Condoms; D004203:Disinfection; D005544:Forecasting; D015658:HIV Infections / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control / Q000635:transmission; D015528:HIV Seroprevalence; D015438:Health Behavior; D006801:Humans; D009339:Needles; D010353:Patient Education as Topic; D011159:Population Surveillance; D011635:Public Health Administration; D012106:Research; D012307:Risk Factors; D016320:Substance Abuse Treatment Centers; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000517:prevention & control; D014505:Urban Population